Details for Patent: 4,842,864

Summary for Patent: 4,842,864

Title:	Self-adhesive device for the percutaneous administration of an active ingredient
Abstract:	The present invention relates to a novel self-adhesive matrix for the percutaneous administration of an active ingredient. This matrix comprises a combination of the following: (a) 40 to 60 parts by weight of an ethylene/vinyl acetate copolymer material, (b) 40 to 60 parts by weight of a higher aliphatic monoalcohol compound, (c) 1 to 20 parts by weight of a cellulose derivative material, (d) 0.1 to 8 parts by weight of a polyhydric alcohol compound, and (e) 0.01 to 10 parts by weight of an active ingredient which can be administered percutaneously, the weight ratio a+c/b+d being between 0.7 and 1.3.
Inventor(s):	Guillemet; Alain (Dijon, FR), Teillaud; Eric (Talant, FR), Reginault; Philippe (Fontaine les Dijon, FR)
Assignee:	Laboratories D'Hygiene et de Dietetique (Paris, FR)
Application Number:	07/174,414
Patent Claim Types: see list of patent claims	Compound; Use;

Drugs Protected by US Patent 4,842,864

Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	TE	Type	RLD	RS	Patent No.	Patent Expiration	Product	Substance	Delist Req.	Patented / Exclusive Use	Submissiondate

Foreign Priority and PCT Information for Patent: 4,842,864

Foriegn Application Priority Data
Foreign Country	Foreign Patent Number	Foreign Patent Date
France	87 04133	Mar 25, 1987

International Family Members for US Patent 4,842,864

Country	Patent Number	Estimated Expiration	Supplementary Protection Certificate	SPC Country	SPC Expiration
Austria	69724
Germany	3866408
European Patent Office	0288336
Spain	2027773
France	2612785
Greece	3003887